Crawford Pharmaceuticals one of the leading suppliers of dermatology products for a range of skin conditions

Pharmaceutical products sales across major international markets are more than €250 billion of which dermatology products account for more than €8 billion. Crawford Healthcare is focusing efforts on developing domestic and international sales opportunities in this sector through organic growth and acquisition. Current key areas include Psoriasis, Eczema, Contact Dermatitis, Photodermatology and prevention of Photodamage.
Click Here To Find Out More

Latest News

Buyout of Crawford Pharmaceuticals

01/08/2009

Crawford Healthcare Ltd trading as Crawford Pharmaceuticals is pleased to announce the successful completion of the buyout from previous ownership.

read more